Should I buy or sell Edap Tms stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Edap Tms in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EDAP shares. View EDAP analyst ratings or view top-rated stocks .

What is Edap Tms' stock price target for 2024?

2 analysts have issued 12-month target prices for Edap Tms' shares. Their EDAP share price targets range from $9.00 to $19.00. On average, they predict the company's stock price to reach $14.67 in the next year. This suggests a possible upside of 99.3% from the stock's current price. View analysts price targets for EDAP or view top-rated stocks among Wall Street analysts .

How have EDAP shares performed in 2024?

Edap Tms' stock was trading at $5.28 at the start of the year. Since then, EDAP shares have increased by 39.4% and is now trading at $7.36. View the best growth stocks for 2024 here .

Are investors shorting Edap Tms?

Edap Tms saw a decline in short interest in March. As of March 31st, there was short interest totaling 104,100 shares, a decline of 7.3% from the March 15th total of 112,300 shares. Based on an average daily trading volume, of 41,200 shares, the days-to-cover ratio is presently 2.5 days. View Edap Tms' Short Interest .

When is Edap Tms' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 15th 2024. View our EDAP earnings forecast .

How were Edap Tms' earnings last quarter?

Edap Tms S.A. (NASDAQ:EDAP) issued its earnings results on Wednesday, November, 17th. The medical equipment provider reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.02. The medical equipment provider had revenue of $11.09 million for the quarter, compared to analyst estimates of $12.53 million. Edap Tms had a negative trailing twelve-month return on equity of 34.33% and a negative net margin of 35.03%. During the same period in the prior year, the business earned ($0.04) earnings per share.

What guidance has Edap Tms issued on next quarter's earnings?

Edap Tms updated its FY 2023 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $65.4 million-$65.4 million, compared to the consensus revenue estimate of $63.0 million.

What other stocks do shareholders of Edap Tms own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Edap Tms investors own include Energous (WATT) , Weatherford International (WFT) , CTI BioPharma (CTIC) , Petróleo Brasileiro S.A. - Petrobras (PBR) , Kandi Technologies Group (KNDI) , Misonix (MSON) , Achillion Pharmaceuticals (ACHN) , Advanced Micro Devices (AMD) , Destination Maternity (DESTQ) and Pacific Drilling (PACDQ) .

Who are Edap Tms' major shareholders?

Edap Tms' stock is owned by a variety of retail and institutional investors. Top institutional investors include Miracle Mile Advisors LLC (0.05%).

How do I buy shares of Edap Tms?

Shares of EDAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:EDAP

Edap Tms (EDAP) Stock Price, News & Analysis

→ Biden replacement revealed? (From Paradigm Press) (Ad)

Free EDAP Stock Alerts

$7.38

+0.25 (+3.51%)

(As of 11:44 AM ET)

Compare

Today's Range: $7.02
▼
$7.38
50-Day Range: $5.76
▼
$8.50
52-Week Range: $3.60
▼
$12.23

Volume: 3,055 shs
Average Volume: 39,494 shs
Market Capitalization: $273.80 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $14.67

Get Edap Tms alerts:

Edap Tms MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 99.3% Upside
$14.67 Price Target
Short Interest: Healthy
0.28% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.38
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.31) to ($0.22) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.92 out of 5 stars

Medical Sector

369th out of 918 stocks

Electromedical Equipment Industry

5th out of 19 stocks

3.5

Analyst's Opinion

Consensus Rating
Edap Tms has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Edap Tms has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.28% of the outstanding shares of Edap Tms have been sold short.
Short Interest Ratio / Days to Cover
Edap Tms has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Edap Tms has recently decreased by 7.30%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Edap Tms does not currently pay a dividend.
Dividend Growth
Edap Tms does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for EDAP.

2.4

News and Social Media Coverage

News Sentiment
Edap Tms has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Edap Tms this week, compared to 1 article on an average week.
MarketBeat Follows
6 people have added Edap Tms to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Edap Tms insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.23% of the stock of Edap Tms is held by insiders.
Percentage Held by Institutions
62.74% of the stock of Edap Tms is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Edap Tms are expected to grow in the coming year, from ($0.31) to ($0.22) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Edap Tms is -11.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Edap Tms is -11.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Edap Tms has a P/B Ratio of 4.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Darwin

Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report

Eager to enhance your investment strategies with foresight? Dive into our intriguing report: "The Top 3 AI Stocks for 2024." Gain profound insights and uncover the secrets with just a click! Why This Report Is Your Gateway to Success: * Expertly Curated: Delve into the AI stocks handpicked by our market analysts for 2024's success story. * In-Depth Analysis: Dive deep into comprehensive profiles and explore each top stock. (**By clicking the link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.)

[Get Your Insights Now]

About Edap Tms Stock (NASDAQ:EDAP)

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. The company serves hospitals, urology clinics, and research institutions. EDAP TMS S.A. was incorporated in 1979 and is based in Lyon, France.

EDAP Stock Price History

30 days | 90 days | 365 days | Advanced Chart

EDAP Stock News Headlines

April 19, 2024 | americanbankingnews.com

Edap Tms (NASDAQ:EDAP) Stock Rating Lowered by StockNews.com

April 17, 2024 | americanbankingnews.com

Medios (OTCMKTS:MEDOF) and Edap Tms (NASDAQ:EDAP) Head to Head Analysis

April 19, 2024 | Tips4Traders (Ad)

Uncover this 2024 Hidden Gem

Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.

April 13, 2024 | americanbankingnews.com

StockNews.com Upgrades Edap Tms (NASDAQ:EDAP) to "Hold"

April 12, 2024 | americanbankingnews.com

Edap Tms (NASDAQ:EDAP) Stock Crosses Above Two Hundred Day Moving Average of $6.24

April 5, 2024 | msn.com

EDAP TMS files for $125M mixed shelf offering

April 1, 2024 | markets.businessinsider.com

EDAP TMS: Strong Buy Rating on Robust Revenue Growth and Expanding Market Presence

March 30, 2024 | finance.yahoo.com

EDAP TMS S.A. (NASDAQ:EDAP) Just Reported Earnings, And Analysts Cut Their Target Price

April 19, 2024 | Tips4Traders (Ad)

Uncover this 2024 Hidden Gem

March 29, 2024 | finance.yahoo.com

EDAP TMS S.A. (NASDAQ:EDAP) Q4 2023 Earnings Call Transcript

March 27, 2024 | investorplace.com

EDAP Stock Earnings: Edap TMS Misses EPS, Beats Revenue for Q4 2023

March 27, 2024 | msn.com

EDAP TMS S.A. GAAP EPS of -$0.15 misses by $0.09, revenue of $21.3M beats by $1.69M

March 27, 2024 | finance.yahoo.com

EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results

March 26, 2024 | msn.com

EDAP TMS S.A. Q4 2023 Earnings Preview

March 26, 2024 | markets.businessinsider.com

Edap TMS earnings preview: what Wall Street is expecting

March 13, 2024 | globenewswire.com

EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024

March 6, 2024 | globenewswire.com

EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

March 5, 2024 | msn.com

EDAP obtains FDA breakthrough status for endometriosis device

March 4, 2024 | globenewswire.com

EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis

February 29, 2024 | msn.com

European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading

February 29, 2024 | msn.com

EDAP TMS S.A. reports Q4 results

February 29, 2024 | globenewswire.com

EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues

February 27, 2024 | msn.com

European Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading

February 23, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Dynavax (DVAX) and EDAP TMS (EDAP)

February 18, 2024 | seekingalpha.com

EDAP EDAP TMS S.A.

February 1, 2024 | finance.yahoo.com

EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis

January 30, 2024 | finance.yahoo.com

Tumor Ablation Market Set to Soar Past USD 4.08 Billion by 2030 | Skyquest Technology

See More Headlines

Receive EDAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Edap Tms and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/17/2021
Today: 4/19/2024
Next Earnings (Estimated): 5/15/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: NASDAQ:EDAP
CUSIP: N/A
CIK: 1041934
Web: www.edap-tms.com
Phone: (347) 215-3150
Fax: 33-04-72-15-31-51
Employees: 307
Year Founded: 1979

Price Target and Rating

Average Stock Price Target: $14.67
High Stock Price Target: $19.00
Low Stock Price Target: $9.00
Potential Upside/Downside: +99.3%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.63)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-22,920,000.00
Net Margins: -35.03%
Pretax Margin: -33.98%
Return on Equity: -34.33%
Return on Assets: -22.28%

Debt

Debt-to-Equity Ratio: 0.04
Current Ratio: 2.84
Quick Ratio: 2.30

Sales & Book Value

Annual Sales: $65.42 million
Price / Sales: 4.17
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.66 per share
Price / Book: 4.43

Miscellaneous

Outstanding Shares: 37,100,000
Free Float: 37,019,000
Market Cap: $273.06 million
Optionable: Optionable
Beta: 0.74

Social Links

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Marc Oczachowski (Age 54)
Executive Chairman
Mr. Ryan Rhodes (Age 62)
CEO & Director
Mr. Ken Mobeck (Age 53)
Chief Financial Officer
Mr. Carre Emmanuel
Chief Operating Officer
Mr. Francois Dietsch (Age 48)
Chief Accounting Officer
Ms. Blandine Confort
Head of Legal Affairs & Investor Relations and Secretary
Mr. Frederic Pech (Age 55)
President of EDAP TMS France
Mr. Jean-Francois Bachelard (Age 60)
President & Chief Executive Officer of Edaptechnomed Co. Ltd.

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

EDAP Stock Analysis - Frequently Asked Questions

Should I buy or sell Edap Tms stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Edap Tms in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EDAP shares.
View EDAP analyst ratings or view top-rated stocks.
What is Edap Tms' stock price target for 2024?: 2 analysts have issued 12-month target prices for Edap Tms' shares. Their EDAP share price targets range from $9.00 to $19.00. On average, they predict the company's stock price to reach $14.67 in the next year. This suggests a possible upside of 99.3% from the stock's current price.
View analysts price targets for EDAP or view top-rated stocks among Wall Street analysts.
How have EDAP shares performed in 2024?: Edap Tms' stock was trading at $5.28 at the start of the year. Since then, EDAP shares have increased by 39.4% and is now trading at $7.36.
View the best growth stocks for 2024 here.
Are investors shorting Edap Tms?: Edap Tms saw a decline in short interest in March. As of March 31st, there was short interest totaling 104,100 shares, a decline of 7.3% from the March 15th total of 112,300 shares. Based on an average daily trading volume, of 41,200 shares, the days-to-cover ratio is presently 2.5 days.
View Edap Tms' Short Interest.
When is Edap Tms' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 15th 2024.
View our EDAP earnings forecast.
How were Edap Tms' earnings last quarter?: Edap Tms S.A. (NASDAQ:EDAP) issued its earnings results on Wednesday, November, 17th. The medical equipment provider reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.02. The medical equipment provider had revenue of $11.09 million for the quarter, compared to analyst estimates of $12.53 million. Edap Tms had a negative trailing twelve-month return on equity of 34.33% and a negative net margin of 35.03%. During the same period in the prior year, the business earned ($0.04) earnings per share.

What guidance has Edap Tms issued on next quarter's earnings?: Edap Tms updated its FY 2023 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $65.4 million-$65.4 million, compared to the consensus revenue estimate of $63.0 million.
What other stocks do shareholders of Edap Tms own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Edap Tms investors own include Energous (WATT), Weatherford International (WFT), CTI BioPharma (CTIC), Petróleo Brasileiro S.A. - Petrobras (PBR), Kandi Technologies Group (KNDI), Misonix (MSON), Achillion Pharmaceuticals (ACHN), Advanced Micro Devices (AMD), Destination Maternity (DESTQ) and Pacific Drilling (PACDQ).
Who are Edap Tms' major shareholders?: Edap Tms' stock is owned by a variety of retail and institutional investors. Top institutional investors include Miracle Mile Advisors LLC (0.05%).
How do I buy shares of Edap Tms?: Shares of EDAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:EDAP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial